Cited by 81Malaria Research and ControlComplement system in diseasesPregnancy and preeclampsia studies

C5a Enhances Dysregulated Inflammatory and Angiogenic Responses to Malaria In Vitro: Potential Implications for Placental Malaria

Open access
Conroy, Andrea, Serghides, Lena, Finney, Constance, Owino, Simon O., Kumar, Sanjeev, Gowda, D. Channe, Liles, W. Conrad, Moore, Julie M. +1 more·2009·PLoS ONE

Abstract

BACKGROUND: Placental malaria (PM) is a leading cause of maternal and infant mortality. Although the accumulation of parasitized erythrocytes (PEs) and monocytes within the placenta is thought to contribute to the pathophysiology of PM, the molecular mechanisms underlying PM remain unclear. Based on the hypothesis that excessive complement activation may contribute to PM, in particular generation of the potent inflammatory peptide C5a, we investigated the role of C5a in the pathogenesis of PM in vitro and in vivo. METHODOLOGY AND PRINCIPAL FINDINGS: Using primary human monocytes, the interaction between C5a and malaria in vitro was assessed. CSA- and CD36-binding PEs induced activation of C5 in the presence of human serum. Plasmodium falciparum GPI (pfGPI) enhanced C5a receptor expression (CD88) on monocytes, and the co-incubation of monocytes with C5a and pfGPI resulted in the synergistic induction of cytokines (IL-6, TNF, IL-1beta, and IL-10), chemokines (IL-8, MCP-1, MIP1alpha, MIP1beta) and the anti-angiogenic factor sFlt-1 in a time and dose-dependent manner. This dysregulated response was abrogated by C5a receptor blockade. To assess the potential role of C5a in PM, C5a plasma levels were measured in malaria-exposed primigravid women in western Kenya. Compared to pregnant women without malaria, C5a levels were significantly elevated in women with PM. CONCLUSIONS AND SIGNIFICANCE: These results suggest that C5a may contribute to the pathogenesis of PM by inducing dysregulated inflammatory and angiogenic responses that impair placental function.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1371/journal.pone.0004953

Cites

70 of 70 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

1 of the 71 references couldn’t be matched to a known paper.

Cited by

Sorted by citations

Authors
Conroy, A., Serghides, L., Finney, C., Owino, S. O., Kumar, S., Gowda, D. C., Liles, W. C., Moore, J. M., & Kain, K. C.
Affiliations
  • University of Toronto (CA)
  • University of Georgia (US)
  • Pennsylvania State University (US)
  • University Health Network (CA)
Corresponding author
Kain, Kevin C.
Venue
PLoS ONE
Published
2009-03-24
Volume
4
Issue
3
Pages
e4953
ISSN
1932-6203 (ISSN-L)
OpenAlex
W2002561997
Cited by
81
References
71
Citations by year
2026: 3 · 2024: 2 · 2023: 2 · 2022: 4 · 2021: 4 · 2020: 4 · 2019: 6 · 2018: 3 · 2017: 4 · 2016: 3 · 2015: 11 · 2014: 4 · 2013: 12 · 2012: 10
FWCI
6.39
Type
journal article
Language
en
Open access
Locations
  • PLoS ONE (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
  • Figshare (submittedVersion, cc-by)
Funders
  • Genome Canada
  • Ontario Genomics
  • Ontario Genomics Institute
  • Canada Research Chairs (13721)
  • National Institutes of Health
  • U.S. Public Health Service (R01050240)
  • Canadian Institutes of Health Research (13721, MT-13721)
  • National Institute of Allergy and Infectious Diseases (R01AI050240)
Topics
  • Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Malaria Research and Control
  • Life Sciences › Immunology and Microbiology › Immunology › Complement system in diseases
  • Health Sciences › Medicine › Obstetrics and Gynecology › Pregnancy and preeclampsia studies
Keywords
placental malaria, C5a, complement activation, Plasmodium falciparum, monocytes, soluble fms-like tyrosine kinase-1, angiogenesis, inflammation, cytokines, chemokines, placenta, primigravid women, malaria in pregnancy
MeSH terms
Animals, Cells, Cultured, Female, Humans, Inflammation, Kenya, Malaria, Monocytes, Neovascularization, Pathologic, Placenta, Plasmodium falciparum, Pregnancy, Complement C5a

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review